
Sabiha Naim Qazi
Examiner (ID: 14019, Phone: (571)272-0622 , Office: P/1621 )
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1621, 1611, 1627, 1202, 1616, 1612, 1629, 1628 |
| Total Applications | 2032 |
| Issued Applications | 930 |
| Pending Applications | 195 |
| Abandoned Applications | 909 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7265016
[patent_doc_number] => 20040242552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'New use of antimineralocorticoid compounds against narcotic withdrawal syndrome'
[patent_app_type] => new
[patent_app_number] => 10/858320
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5994
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242552.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858320
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858320 | New use of antimineralocorticoid compounds against narcotic withdrawal syndrome | May 31, 2004 | Abandoned |
Array
(
[id] => 5107665
[patent_doc_number] => 20070066543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity'
[patent_app_type] => utility
[patent_app_number] => 10/557454
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 8726
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20070066543.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557454
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557454 | Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity | May 20, 2004 | Abandoned |
Array
(
[id] => 7432829
[patent_doc_number] => 20040209854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods'
[patent_app_type] => new
[patent_app_number] => 10/847846
[patent_app_country] => US
[patent_app_date] => 2004-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7239
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209854.pdf
[firstpage_image] =>[orig_patent_app_number] => 10847846
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/847846 | Method for the preparation of fluticasone and related 17β-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods | May 17, 2004 | Issued |
Array
(
[id] => 7380110
[patent_doc_number] => 20040220418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Method of synthesizing 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol'
[patent_app_type] => new
[patent_app_number] => 10/847040
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3831
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220418.pdf
[firstpage_image] =>[orig_patent_app_number] => 10847040
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/847040 | Method of synthesizing 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol | May 16, 2004 | Issued |
Array
(
[id] => 6906181
[patent_doc_number] => 20050101576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes'
[patent_app_type] => utility
[patent_app_number] => 10/841820
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 31280
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101576.pdf
[firstpage_image] =>[orig_patent_app_number] => 10841820
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/841820 | Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes | May 9, 2004 | Abandoned |
Array
(
[id] => 7297300
[patent_doc_number] => 20040214801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => '9-Substituted minocycline compounds'
[patent_app_type] => new
[patent_app_number] => 10/839023
[patent_app_country] => US
[patent_app_date] => 2004-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11311
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214801.pdf
[firstpage_image] =>[orig_patent_app_number] => 10839023
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/839023 | 9-substituted minocycline compounds | May 3, 2004 | Issued |
Array
(
[id] => 7425080
[patent_doc_number] => 20040208926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Solubilized sertraline compositions'
[patent_app_type] => new
[patent_app_number] => 10/838929
[patent_app_country] => US
[patent_app_date] => 2004-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7012
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20040208926.pdf
[firstpage_image] =>[orig_patent_app_number] => 10838929
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/838929 | Solubilized sertraline compositions | May 3, 2004 | Abandoned |
Array
(
[id] => 5051916
[patent_doc_number] => 20070032461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => '1,3 Aclyated 24-keto-vitamin d3 compounds and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/554769
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20633
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20070032461.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554769
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554769 | 1,3 Aclyated 24-keto-vitamin d3 compounds and methods of use thereof | Apr 29, 2004 | Abandoned |
Array
(
[id] => 7432821
[patent_doc_number] => 20040209853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Orally active 7.alpha.-alkyl androgens'
[patent_app_type] => new
[patent_app_number] => 10/837061
[patent_app_country] => US
[patent_app_date] => 2004-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10096
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209853.pdf
[firstpage_image] =>[orig_patent_app_number] => 10837061
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/837061 | Orally active 7.alpha.-alkyl androgens | Apr 28, 2004 | Abandoned |
Array
(
[id] => 7070367
[patent_doc_number] => 20050245752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Synthesis of unsymmetric anthracene compounds'
[patent_app_type] => utility
[patent_app_number] => 10/834826
[patent_app_country] => US
[patent_app_date] => 2004-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5332
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20050245752.pdf
[firstpage_image] =>[orig_patent_app_number] => 10834826
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/834826 | Synthesis of unsymmetric anthracene compounds | Apr 28, 2004 | Abandoned |
Array
(
[id] => 7255527
[patent_doc_number] => 20040259732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Treatment of plants and plant propagation materials with an antioxidant to improve plant health and/or yield'
[patent_app_type] => new
[patent_app_number] => 10/832578
[patent_app_country] => US
[patent_app_date] => 2004-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14198
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259732.pdf
[firstpage_image] =>[orig_patent_app_number] => 10832578
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/832578 | Treatment of plants and plant propagation materials with an antioxidant to improve plant health and/or yield | Apr 26, 2004 | Abandoned |
Array
(
[id] => 7329832
[patent_doc_number] => 20040254125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Anthelmintic composition'
[patent_app_type] => new
[patent_app_number] => 10/493716
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6558
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254125.pdf
[firstpage_image] =>[orig_patent_app_number] => 10493716
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/493716 | Anthelmintic composition | Apr 22, 2004 | Abandoned |
Array
(
[id] => 5829075
[patent_doc_number] => 20060063760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Hydroxamic acids useful in the treatment of hyper-proliferative disorders'
[patent_app_type] => utility
[patent_app_number] => 10/554390
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49947
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063760.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554390
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554390 | Hydroxamic acids useful in the treatment of hyper-proliferative disorders | Apr 15, 2004 | Abandoned |
Array
(
[id] => 7436302
[patent_doc_number] => 20040266865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'SHIP 1 modulators'
[patent_app_type] => new
[patent_app_number] => 10/825858
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7037
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266865.pdf
[firstpage_image] =>[orig_patent_app_number] => 10825858
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/825858 | SHIP 1 modulators | Apr 15, 2004 | Abandoned |
Array
(
[id] => 5678572
[patent_doc_number] => 20060183928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds'
[patent_app_type] => utility
[patent_app_number] => 10/824661
[patent_app_country] => US
[patent_app_date] => 2004-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 34986
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183928.pdf
[firstpage_image] =>[orig_patent_app_number] => 10824661
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/824661 | Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds | Apr 14, 2004 | Abandoned |
Array
(
[id] => 460001
[patent_doc_number] => 07241747
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-10
[patent_title] => '2-propylidene-19-nor-vitamin D compounds'
[patent_app_type] => utility
[patent_app_number] => 10/821479
[patent_app_country] => US
[patent_app_date] => 2004-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 20892
[patent_no_of_claims] => 103
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/241/07241747.pdf
[firstpage_image] =>[orig_patent_app_number] => 10821479
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/821479 | 2-propylidene-19-nor-vitamin D compounds | Apr 8, 2004 | Issued |
Array
(
[id] => 5602946
[patent_doc_number] => 20060293291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => '2-Propylidene-19-nor-vitamin d compounds'
[patent_app_type] => utility
[patent_app_number] => 10/544163
[patent_app_country] => US
[patent_app_date] => 2004-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 20855
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20060293291.pdf
[firstpage_image] =>[orig_patent_app_number] => 10544163
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/544163 | 2-Propylidene-19-nor-vitamin d compounds | Apr 8, 2004 | Abandoned |
Array
(
[id] => 168423
[patent_doc_number] => 07666846
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-23
[patent_title] => 'Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi'
[patent_app_type] => utility
[patent_app_number] => 10/550907
[patent_app_country] => US
[patent_app_date] => 2004-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 16601
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/666/07666846.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550907
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550907 | Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi | Apr 1, 2004 | Issued |
Array
(
[id] => 7465721
[patent_doc_number] => 20040198608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => '6-Alkyl or alkenyl-4-aminopicolinates and their use as herbicides'
[patent_app_type] => new
[patent_app_number] => 10/816611
[patent_app_country] => US
[patent_app_date] => 2004-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8854
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198608.pdf
[firstpage_image] =>[orig_patent_app_number] => 10816611
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/816611 | 6-alkyl or alkenyl-4-aminopicolinates and their use as herbicides | Apr 1, 2004 | Issued |
Array
(
[id] => 7447343
[patent_doc_number] => 20040186089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Compounds useful in the treatment of anthrax'
[patent_app_type] => new
[patent_app_number] => 10/491235
[patent_app_country] => US
[patent_app_date] => 2004-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4667
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20040186089.pdf
[firstpage_image] =>[orig_patent_app_number] => 10491235
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/491235 | Compounds useful in the treatment of anthrax | Mar 28, 2004 | Abandoned |